Heparin Resistance: Predictors and Outcomes
Heparin Resistance During Off-pump Coronary Artery Bypass Graft Surgery: Predictors and Clinical Implication
1 other identifier
interventional
199
1 country
1
Brief Summary
The investigators evaluated clinical impact of reduced heparin responsiveness (HRreduced) on the incidence of perioperative myocardial infarction (MI) and restenosis at 6 months after off-pump coronary artery bypass graft surgery (OPCAB) and identified its predictors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 7, 2010
CompletedFirst Posted
Study publicly available on registry
January 8, 2010
CompletedFebruary 2, 2012
January 1, 2012
11 months
January 7, 2010
January 31, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidences of postoperative MI and major morbidity
immediate postoperative period
Secondary Outcomes (2)
incidences of cardiac morbidities
6 months following surgery
restenosis of graft vessels
6 months following surgery
Interventions
150 U/kg heparin was administered intravenously at the beginning of graft anastomosis and accepted a perioperative ACT value of around 300 s. Ten minutes after the loading dose, the ACT was measured. An ACT of 300 s or greater was considered as adequate. Then follow up ACT measurement was determined after 30 min from the previous ACT measurement. If ACT fell below the target value of 300 s, an additional dose of heparin was administered. If ACT was between 250 and 299 s, additional 2000 U of heparin was administered and if ACT was between 200 and 249 s then additional 3000 U of heparin was injected. Ten minutes after additional heparin injection, ACT was remeasured.
Eligibility Criteria
You may qualify if:
- enrolling all consecutive patients scheduled for elective isolated multivessel OPCAB between April 2007 and March 2008
You may not qualify if:
- presence of known preoperative coagulopathy, emergency operation or preoperative use of an intra-aortic balloon pump.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yonsei University Severance hospital
Seoul, Seodaemungu, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Duk-Hee Chun, MD
Severance Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2010
First Posted
January 8, 2010
Study Start
April 1, 2007
Primary Completion
March 1, 2008
Study Completion
September 1, 2008
Last Updated
February 2, 2012
Record last verified: 2012-01